Ovid Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.About OVID
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY.
OVID Key Statistics
Stock Snapshot
With a market cap of 156.09M, Ovid Therapeutics(OVID) trades at $1.80. The stock has a price-to-earnings ratio of -3.54.
As of 2025-12-23, Ovid Therapeutics(OVID) stock has fluctuated between $1.67 and $1.82. The current price stands at $1.80, placing the stock +7.8% above today's low and -1.1% off the high.
Ovid Therapeutics(OVID) shares are trading with a volume of 2.37M, against a daily average of 1.83M.
During the past year, Ovid Therapeutics(OVID) stock moved between $0.24 at its lowest and $2.01 at its peak.
During the past year, Ovid Therapeutics(OVID) stock moved between $0.24 at its lowest and $2.01 at its peak.
OVID News
Ovid Therapeutics (OVID) announced results from its Phase 1 study of OV350, the first-ever Potassium-Chloride Cotransporter 2, KCC2, direct activator known to b...